| Phase 3 |
| NCT07867002 |
Assessing Survival Outcomes With Checkpoint Inhibition ExteNded vs Discontinued in… |
Endometrial Adenocarcinoma |
Not Yet Recruiting |
2026-10-15 |
| Phase 2 |
| NCT07278557 |
Sparing Parotid Ducts Via MRI Sialography for Reduced Patient-Reported Xerostomia |
Head and Neck Cancer |
Recruiting |
2026-10-13 |
| NCT07740941 |
NeoAdjuvant, Spare-Adjuvant (NASA) in Stage IIIB-IV (M1a) Melanoma |
Melanoma (Skin Cancer) |
Recruiting |
2026-09-30 |
| NCT04083495 |
CD30 CAR for Relapsed/Refractory CD30+ T Cell Lymphoma |
Peripheral T Cell Lymphoma |
Recruiting |
2026-09-24 |
| NCT05578326 |
Study of Trilaciclib and Lurbinectidin |
Lung Cancer |
Recruiting |
2026-09-21 |
| NCT07340541 |
Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies |
Breast Cancer |
Recruiting |
2026-09-18 |
| NCT07685938 |
Pharmacologic Therapies to Mitigate Radiation- Associated Heart Disease |
Chest Wall Tumor |
Recruiting |
2026-09-17 |
| NCT07630168 |
Effects of Infusion Timing on Treatment Response in Solid Tumors |
Lung Cancer |
Recruiting |
2026-09-15 |
| NCT06902311 |
Ultra Hypo-fractionated Adjuvant Whole Breast Radiation Therapy With Simultaneous… |
Breast Cancer |
Recruiting |
2026-09-03 |
| NCT07225114 |
Translation of Acoustic Angiography: Contrast Enhanced Super Resolution (CESR) Imaging |
Breast Cancer |
Recruiting |
2026-06-08 |
| NCT05145400 |
Isa-Rd for Frail and/or Much Older Patients With Newly Diagnosed Multiple Myeloma |
Multiple Myeloma |
Recruiting |
2026-06-02 |
| NCT05472792 |
Compare Adjuvant Monotherapy With Endocrine or Accelerated Partial Breast Irradiation… |
Breast Cancer |
Recruiting |
2026-05-26 |
| NCT06727773 |
Memantine and Exercise to Improve Cognitive Function and Modulate Biological Pathways of… |
Breast Cancer |
Recruiting |
2026-05-06 |
| NCT07276880 |
Preoperative Chemotherapy, Pembrolizumab and Low or High Dose RADiation in an Expansion… |
Breast Cancer |
Recruiting |
2026-04-27 |
| NCT07069595 |
PREDICT-RD: ctDNA Surveillance in TNBC With Residual Disease |
Breast Cancer |
Recruiting |
2026-04-22 |
| NCT03977233 |
Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer |
Pancreatic Ductal Adenocarcinoma (PDAC) |
Recruiting |
2026-01-13 |
| NCT07078838 |
Tirzepatide in Women With Obesity and Endometrial Intra-epithelial Neoplasia or Grade 1… |
Endometrial Cancer |
Not Yet Recruiting |
2026-09-28 |
| NCT07605949 |
Revumenib, Azacitidine, and VENetoclax in Newly Diagnosed KMT2A-Rearranged AML |
Leukemia Acute Myeloid |
Not Yet Recruiting |
2026-09-10 |
| NCT07484139 |
H&N NEO-COMBAT XL: Neoadjuvant XL-092 (Zanzalintinib) and Pembrolizumab (Keytruda) in… |
Oral Cavity Squamous Cell Carcinoma |
Not Yet Recruiting |
2026-08-31 |
| NCT07545746 |
Adjuvant 5-Fluorouracil Following Thermal Ablation to Improve HPV Treatment Outcomes in… |
HIV Infections |
Not Yet Recruiting |
2026-08-27 |
| NCT07526597 |
Study on Treatment Outcome Patterns for Patients With CLL After Discontinuation of BTK… |
Chronic Lymphocytic Leukemia |
Not Yet Recruiting |
2026-08-05 |
| NCT03529422 |
Durvalumab With Radiotherapy for Adjuvant Treatment of Intermediate Risk SCCHN |
Larynx |
Active, Not Recruiting |
2026-06-23 |
| NCT04548648 |
A Pilot Study of Acalabrutinib in Relapsed/Refractory Primary and Secondary CNS Lymphomas |
Central Nervous System Lymphoma |
Active, Not Recruiting |
2026-06-10 |
| NCT05911321 |
Isa-Pom-Dex in Elderly/Frail Subjects With RRMM |
Multiple Myeloma |
Active, Not Recruiting |
2026-06-09 |
| NCT03174275 |
Carboplatin, Nab-Paclitaxel, Durvalumab Before Surgery and Adjuvant Therapy in Head and… |
Carcinoma, Squamous Cell |
Active, Not Recruiting |
2026-02-23 |